Furthermore, a recent study has shown that tumor cell vaccines with CD40L and GM-CSF gene transduction have a higher therapeutic efficacy than that of tumor cell vaccines with transduction of each single gene [10]. This evidence concerns the gene CD40LG and neoplasm.